Comparative Efficacy of Nonsteroid Immunosuppressive Medications in Childhood Nephrotic Syndrome
In this study, there was no evidence of difference in time to relapse after cyclophosphamide and calcineurin inhibitor treatment in children with nephrotic syndrome. Cyclophosphamide treatment is shorter in duration and more accessible globally than calcineurin inhibitors.
Authors
- Rahul Chanchlani (ORCID: https://orcid.org/0000-0001-9366-3118)
- Jovanka Vasilevska‐Ristovska (ORCID: https://orcid.org/0000-0002-1465-2523)
- Cal Robinson (ORCID: https://orcid.org/0000-0002-2223-0646)
- Chia Wei Teoh (ORCID: https://orcid.org/0000-0002-5994-0799)
- Leo Levin
- Damien Noone (ORCID: https://orcid.org/0000-0003-3385-6174)
- Josefina Brooke
- Ashlene Maree McKay (ORCID: https://orcid.org/0000-0002-8880-1886)
- Rachel Pearl
- Rulan S. Parekh (ORCID: https://orcid.org/0000-0001-6313-5752)
- Nowrin Aman
- Brian H. Cuthbertson (ORCID: https://orcid.org/0000-0003-4174-9424)
- Valérie S. Langlois (ORCID: https://orcid.org/0000-0003-4031-6838)
- Eddy Fan (ORCID: https://orcid.org/0000-0002-1210-9914)
- Christoph P. B. Licht (ORCID: https://orcid.org/0000-0003-4168-3277)
- Tonny Banh (ORCID: https://orcid.org/0000-0002-5857-7641)
- Vaneet Dhillon
- Seetha Radhakrishnan (ORCID: https://orcid.org/0000-0003-1102-7623)
- Anna Heath
- Véronique Rowley
Institutions
- Sunnybrook Health Science Centre (CA)
- University of Toronto (CA)
- Montreal Children's Hospital (CA)
- Hospital for Sick Children (CA)
- Women's College Hospital (CA)
- McMaster Children's Hospital (CA)
- Health Sciences Centre (CA)
- Public Health Ontario (CA)
- William Osler Health System (CA)
- SickKids Foundation (CA)
- Institute for Clinical Evaluative Sciences (CA)
- Impact (CA)
- University College London (GB)
- McMaster University (CA)
Publication Details
- Journal
- JAMA Pediatrics
- Published
- 2025-01-27
- DOI
- https://doi.org/10.1001/jamapediatrics.2024.5286
- Citations
- 6
- Primary Topic
- Adolescent and Pediatric Healthcare
- Type
- article
- Field-Weighted Citation Impact
- 18.71